Wang et al. (2012) found increased CSF levels of the phosphorylated α-synuclein phospho-Ser129 (PS-129) in PD patients when compared with controls, but lower levels in MSA and PSP of this protein than in PD patients and controls. This evidence concerns the gene SNCA and Parkinson disease.